Maik J. Grundeken

Maik J. Grundeken

Auto-generated profile, based on publicly available information

Maik J. Grundeken

Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in EuroIntervention
Verified
Journal Article
Closed access
RKRobin P. Kraak
Robin P. Kraak
MHMariëlla E.C.J. Hassell
Mariëlla E.C.J. Hassell
MGMaik J. Grundeken
Maik J. Grundeken
KKKarel T. Koch
Karel T. Koch
Jose HenriquesJose Henriques
Jose Henriques
JWJoanna J. Wykrzykowska
Joanna J. Wykrzykowska
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

1 July 2015 in EuroIntervention
Verified
Journal Article
Closed access
KKKarel T. Koch
Karel T. Koch
MGMaik J. Grundeken
Maik J. Grundeken
NVNicola S. Vos
Nicola S. Vos
AIAlexander J.J. Ijsselmuiden
Alexander J.J. Ijsselmuiden
RGRobert-Jan van Geuns
Robert-Jan van Geuns
GAGiovanni Amoroso
Giovanni Amoroso
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

1 September 2015 in EuroIntervention
Verified
Journal Article
Closed access
PBPeter Barlis
Peter Barlis
EPEric K.W. Poon
Eric K.W. Poon
VTVikas Thondapu
Vikas Thondapu
MGMaik J. Grundeken
Maik J. Grundeken
Shengxian TuShengxian Tu
Shengxian Tu
PSPatrick W. Serruys
Patrick W. Serruys
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

24 August 2017 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
MGMaik J. Grundeken
Maik J. Grundeken
CCCarlos Collet
Carlos Collet
YIYuki Ishibashi
Yuki Ishibashi
PGPhilippe Généreux
Philippe Généreux
TMTakashi Muramatsu
Takashi Muramatsu
PSPatrick Serruys
Patrick Serruys

15 January 2014 in Heart
Verified
Journal Article
Closed access
PDF file
MGMaik J Grundeken
Maik J Grundeken
MLMaciej Lesiak
Maciej Lesiak
SASolomon Asgedom
Solomon Asgedom
EGEulogio Garcia
Eulogio Garcia
ABArmando Bethencourt
Armando Bethencourt
JWJoanna J Wykrzykowska
Joanna J Wykrzykowska
Objective We evaluated differences in clinical outcomes between patients who underwent final kissing balloon inflation (FKBI) and patients who did not undergo FKBI in bifurcation treatment using the Tryton Side Branch Stent (Tryton Medical, Durham, North Carolina, USA). Methods Clinical outcomes were defined as target vessel failure (composite of cardiac death, any myocardial infarction and clinically indicated target vessel revascularisation), cardiac death, myocardial infarction (MI), clinically indicated target vessel revascularisation and stent thrombosis. Cumulative event rates were estimated using the Kaplan-Meier method. A multivariable logistic regression analysis was performed to evaluate which factors were potentially associated with FKBI performance. Results Follow-up data was available in 717 (96%) patients with a median follow-up of 190 days. Cardiac death at 1 year occurred more often in the no-FKBI group (1.7% vs 4.6%, respectively, p=0.017), although this difference was no longer observed after excluding patients presenting with ST segment elevation MI (1.6% vs 3.3%, p=0.133). No significant differences were observed concerning the other clinical outcomes. One-year target vessel failure rates were 10.1% in the no-FKBI group and 9.2% in the FKBI group (p=0.257). Multivariable logistic regression analysis identified renal dysfunction, ST segment elevation MI as percutaneous coronary intervention indication, narrow (<30°) bifurcation angle and certain stent platforms as being independently associated with unsuccessful FKBI. Conclusions A lower cardiac death rate was observed in patients in whom FKBI was performed compared with a selection of patients in whom FKBI could not be performed, probably explained by an unbalance in the baseline risk profile of the patients. No differences were observed regarding the other clinical outcomes.

24 April 2015 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
TMTakashi Muramatsu
Takashi Muramatsu
MGMaik J. Grundeken
Maik J. Grundeken
YIYuki Ishibashi
Yuki Ishibashi
SNShimpei Nakatani
Shimpei Nakatani
CGChrysafios Girasis
Chrysafios Girasis
OIOn behalf of the TRYTON Pivotal IDE Coronary Bifurcation Trial Investigators
On behalf of the TRYTON Pivotal IDE Coronary Bifurcation Trial Investigators